PATENT CLAIM ANALYSIS

Application Number: 15902191
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["424", "143100"]

Abstract:
Disclosed are methods and compositions for treating Type I diabetes in a subject. Agents selected from a TLR4 agonist, a TLR4/MD-2 agonist, or a combination thereof may be used in the disclosed methods and compositions. Also disclosed are methods of restoring adaptive immune T cell tolerance, treating pernicious insulitis, improving immune tolerance, and treating autoimmune diseases using the disclosed methods and compositions.

Claim (Index 8):
A method of treating an autoimmune disease in a subject, comprising the step of stimulating TLR4/MD-2.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 88.0
- Lexical Diversity: 1.62791
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15302772', '13645754', '14593644', '13257349', '13862927']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6703757404922096
- 35 USC 102 Novelty (BERT): 0.5985953049051227
- Combined Prediction Score: 0.663197696933501
- Mean Citation Score: 307.796512
- Max Citation Score: 542.1097
- Similarity Product: 430.166150607121

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test